These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21037797)

  • 1. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.
    Zhang N; An MC; Montoro D; Ellerby LM
    PLoS Curr; 2010 Oct; 2():RRN1193. PubMed ID: 21037797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease.
    Al-Gharaibeh A; Culver R; Stewart AN; Srinageshwar B; Spelde K; Frollo L; Kolli N; Story D; Paladugu L; Anwar S; Crane A; Wyse R; Maiti P; Dunbar GL; Rossignol J
    Front Neurosci; 2017; 11():628. PubMed ID: 29209158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Differentiation of Human Neural Progenitor Cells Into Striatal GABAergic Neurons.
    Lin L; Yuan J; Sander B; Golas MM
    Stem Cells Transl Med; 2015 Jul; 4(7):775-88. PubMed ID: 25972145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.
    Camnasio S; Delli Carri A; Lombardo A; Grad I; Mariotti C; Castucci A; Rozell B; Lo Riso P; Castiglioni V; Zuccato C; Rochon C; Takashima Y; Diaferia G; Biunno I; Gellera C; Jaconi M; Smith A; Hovatta O; Naldini L; Di Donato S; Feki A; Cattaneo E
    Neurobiol Dis; 2012 Apr; 46(1):41-51. PubMed ID: 22405424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the Hedgehog pathway.
    El-Akabawy G; Medina LM; Jeffries A; Price J; Modo M
    Stem Cells Dev; 2011 Nov; 20(11):1873-87. PubMed ID: 21345011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient.
    Reddington AE; Rosser AE; Dunnett SB
    Front Cell Neurosci; 2014; 8():398. PubMed ID: 25520619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directly reprogrammed Huntington's disease neural precursor cells generate striatal neurons exhibiting aggregates and impaired neuronal maturation.
    Monk R; Lee K; Jones KS; Connor B
    Stem Cells; 2021 Oct; 39(10):1410-1422. PubMed ID: 34028139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
    Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
    Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease.
    Naphade S; Embusch A; Madushani KL; Ring KL; Ellerby LM
    Front Neurosci; 2017; 11():736. PubMed ID: 29459817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.
    Akimov SS; Jiang M; Kedaigle AJ; Arbez N; Marque LO; Eddings CR; Ranum PT; Whelan E; Tang A; Wang R; DeVine LR; Talbot CC; Cole RN; Ratovitski T; Davidson BL; Fraenkel E; Ross CA
    Hum Mol Genet; 2021 Nov; 30(24):2469-2487. PubMed ID: 34296279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
    Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
    Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
    Malankhanova T; Suldina L; Grigor'eva E; Medvedev S; Minina J; Morozova K; Kiseleva E; Zakian S; Malakhova A
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33182269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal differentiation defects in induced pluripotent stem cells derived from a Prader-Willi syndrome patient.
    Soeda S; Saito R; Fujita N; Fukuta K; Taniura H
    Neurosci Lett; 2019 Jun; 703():162-167. PubMed ID: 30902571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines.
    Niclis JC; Pinar A; Haynes JM; Alsanie W; Jenny R; Dottori M; Cram DS
    Front Cell Neurosci; 2013; 7():37. PubMed ID: 23576953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.
    Ring KL; An MC; Zhang N; O'Brien RN; Ramos EM; Gao F; Atwood R; Bailus BJ; Melov S; Mooney SD; Coppola G; Ellerby LM
    Stem Cell Reports; 2015 Dec; 5(6):1023-1038. PubMed ID: 26651603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
    Castiglioni V; Onorati M; Rochon C; Cattaneo E
    Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin.
    Hamilton J; Brustovetsky T; Sridhar A; Pan Y; Cummins TR; Meyer JS; Brustovetsky N
    Mol Neurobiol; 2020 Feb; 57(2):668-684. PubMed ID: 31435904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.